Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Ozempic and Wegovy are “forever drugs”—once a person stops taking the medications, they typically regain the weight unless ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...